Pharmacokinetics and Pharmacodynamics of Canagliflozin, a Sodium Glucose Co‐Transporter 2 Inhibitor, in Subjects With Type 2 Diabetes Mellitus
Year: 2013
Type: article
Study design: Clinical Trial
DOI: 10.1002/jcph.88
Authors: Damayanthi Devineni, Christopher R. Curtin, David Polidori, Maria J. Gutierrez, Joseph Murphy, Sarah Rusch, Paul L. Rothenberg
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1606165384
